Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03399890
Other study ID # 10-544
Secondary ID
Status Completed
Phase N/A
First received December 11, 2017
Last updated January 23, 2018
Start date May 10, 2017
Est. completion date October 10, 2017

Study information

Verified date January 2018
Source Ankara University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Neurological physical exam is a very important outcome that should be evaluated as soon as possible after every lumbar procedures. The aim of this study was to evaluate the neurological physical examination time after lumbar procedures.


Description:

Neurological physical exam is a very important outcome that should be evaluated as soon as possible after every lumbar procedures. By that early postoperative neurological complications can be revealed and early interventions planned. The aim of this study was to evaluate the neurological physical examination time after lumbar procedures. Two routinely used different reversal agents (neostigmine or sugammadex) were compared according reversal times and muscle strength on PACU admission.


Recruitment information / eligibility

Status Completed
Enrollment 107
Est. completion date October 10, 2017
Est. primary completion date July 10, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Lumber surgery

- ASA I-II

- Elective surgery

Exclusion Criteria:

- Emergency cases

- Age lower than 18

- Age higher than 65

- Patient with existing neurological deficit

- Patient with existing renal insufficiency

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Neurological physical exam
Neurological physical exam is performed in all patients at the OR table, immediately after the operation.

Locations

Country Name City State
Turkey Ankara University Faculty of Medicine Ankara

Sponsors (1)

Lead Sponsor Collaborator
Ankara University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neurological physical examination time Neurological physical examination time postoperative first 30 minutes
Secondary Muscle strength at PACU transfer Muscle strength at PACU transfer (evaluated with a 5 point scale) 0/5: no contraction in muscles 1/5: muscle flicker but no movement 2/5: movement possible bit not against gravity (test the joint in its horizontal plane) 3/5: moment possible against gravity but not against resistance by the examiner 4/5: movement possible against resistance by the examiner 5/5: normal strength postoperative first 60 minutes
See also
  Status Clinical Trial Phase
Completed NCT03095742 - Bedside Monitoring of Cerebral Energy State During the Peri-cardiac Arrest Period N/A
Not yet recruiting NCT05947617 - Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS). Phase 1
Enrolling by invitation NCT06360666 - Clinical Outcomes in Adult Patients Undergoing Laparoscopic Surgery Under Neuraxial Anesthesia
Not yet recruiting NCT05363098 - The Cerebral-Respiratory Interaction During Spontaneous Breathing Ventilation in Neurosurgical Patients (CeRes-SB)
Recruiting NCT05843214 - Transcranial Doppler, Optic Nerve Envelope Diameter and Quantitative Pupillometry Measurements
Active, not recruiting NCT04755439 - Without Cerebral perfusıon Under Deep Hypothermic Circulatory Arrest (DHCA) (18 Deegres) the Comparison of the Undergoing Proximal Aortic Surgery Patients Preoperative and Postoperative Diffusion Magnetic Resonance Imaging's and Neuron Specific Enolase Enzyms Levels. N/A
Completed NCT04363749 - COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities N/A
Completed NCT05097066 - Patterns and Outcomes of Neurosurgery in England Over a Five-year Period